You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NRIX Sale Disclosure
Hansen Gwenn · SEC Form 4 · Filed Oct 15, 2026
Sale
Calculated transaction value
$36.3K
Hansen Gwenn Chief Scientific Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Oct 15, 2026
Public filing date
Oct 15, 2026
Filing lag
Filed same day
NRIX daily price context
Close on/before transaction
$24.95
Oct 15, 2026
First close after public filing
$24.42
Oct 16, 2026
Return after filing · so far
-33.13%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,452 shares @ $25
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817160-26-000021
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$39K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 15, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Oct 15, 2026 | $2.7K |
| Nurix Therapeutics, Inc. NRIX Current | Sale | Oct 15, 2026 | $36.3K |